China’s determination to use a centralized bidding system to trim public health spending would directly impact purchasing of “high-value” medical devices under recent draft guidelines issued by the country’s Ministry of Health. New pricing pressures on both multinational and domestic device makers are a likely result, industry analysts say.
The Chinese Ministry of Health released a first draft proposal in March 2012 outlining requirements for county-level public hospitals to participate in provincial bidding to purchase medical devices such as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?